CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Price & Overview

NASDAQ:CLOV • US18914F1030

Current stock price

1.89 USD
0 (0%)
At close:
1.8899 USD
0 (-0.01%)
After Hours:

The current stock price of CLOV is 1.89 USD. Today CLOV is down by 0%. In the past month the price decreased by -6.44%. In the past year, price decreased by -49.19%.

CLOV Key Statistics

52-Week Range1.85 - 3.92
Current CLOV stock price positioned within its 52-week range.
1-Month Range1.85 - 2.25
Current CLOV stock price positioned within its 1-month range.
Market Cap
991.626M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.17
Dividend Yield
N/A

CLOV Stock Performance

Today
0%
1 Week
-4.55%
1 Month
-6.44%
3 Months
-26.74%
Longer-term
6 Months -37.62%
1 Year -49.19%
2 Years +138.04%
3 Years +123.64%
5 Years -75.00%
10 Years N/A

CLOV Stock Chart

CLOVER HEALTH INVESTMENTS CO / CLOV Daily stock chart

CLOV Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to CLOV. When comparing the yearly performance of all stocks, CLOV is a bad performer in the overall market: 91.2% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CLOV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CLOV. While CLOV seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CLOV Earnings

On February 26, 2026 CLOV reported an EPS of -0.1 and a revenue of 487.71M. The company beat EPS expectations (5.12% surprise) and beat revenue expectations (2.37% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported-$0.10
Revenue Reported487.707M
EPS Surprise 5.12%
Revenue Surprise 2.37%

CLOV Forecast & Estimates

10 analysts have analysed CLOV and the average price target is 2.92 USD. This implies a price increase of 54.48% is expected in the next year compared to the current price of 1.89.

For the next year, analysts expect an EPS growth of 86% and a revenue growth 46.4% for CLOV


Analysts
Analysts76
Price Target2.92 (54.5%)
EPS Next Y86%
Revenue Next Year46.4%

CLOV Groups

Sector & Classification

CLOV Financial Highlights

Over the last trailing twelve months CLOV reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -88.89% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-58.23M
Industry RankSector Rank
PM (TTM) N/A
ROA -10.4%
ROE -17.08%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-150%
Sales Q2Q%44.74%
EPS 1Y (TTM)-88.89%
Revenue 1Y (TTM)N/A

CLOV Ownership

Ownership
Inst Owners30%
Shares524.67M
Float414.71M
Ins Owners2.59%
Short Float %9.28%
Short Ratio6.47

About CLOV

Company Profile

CLOV logo image Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

Company Info

IPO: 2020-06-12

CLOVER HEALTH INVESTMENTS CO

30 Montgomery Street

Jersey City NEW JERSEY 37067 US

CEO: Vivek Garipalli

Employees: 570

CLOV Company Website

CLOV Investor Relations

Phone: 12014322133

CLOVER HEALTH INVESTMENTS CO / CLOV FAQ

What does CLOVER HEALTH INVESTMENTS CO do?

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.


What is the current price of CLOV stock?

The current stock price of CLOV is 1.89 USD.


Does CLOV stock pay dividends?

CLOV does not pay a dividend.


What is the ChartMill technical and fundamental rating of CLOV stock?

CLOV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the market expecting CLOV stock to perform?

10 analysts have analysed CLOV and the average price target is 2.92 USD. This implies a price increase of 54.48% is expected in the next year compared to the current price of 1.89.


Can you provide the sector and industry classification for CLOVER HEALTH INVESTMENTS CO?

CLOVER HEALTH INVESTMENTS CO (CLOV) operates in the Health Care sector and the Health Care Providers & Services industry.